Lupus myocarditis: A case–control study from China

Chinese Medical Journal

Volumn 128, Issue 19, 2015, Pages 2588-2594

  Zhang, Li ^a,b   Zhu, Yan Lin ^a   Li, Meng Tao ^a,b   Gao, Na ^a,b   You, Xin ^a,b   Wu, Qing Jun ^a,b   Su, Jin Mei ^a,b   Shen, Min ^a,b   Zhao, Li Dan ^a,b   Liu, Jin Jing ^a,b   Zhang, Feng Chun ^a,b   Zhao, Yan ^a,b   Zeng, Xiao Feng ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Echocardiography; Lupus myocarditis; Prognosis; Systemic lupus erythematosus

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUPUS MYOCARDITIS; MALE; MORTALITY; MYOCARDITIS; PLASMAPHERESIS; RETROSPECTIVE STUDY; RISK FACTOR; SIMPLIFIED DISEASE ACTIVITY INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS; COMPLICATION; MULTIVARIATE ANALYSIS;

ADULT; CASE-CONTROL STUDIES; CHINA; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIVARIATE ANALYSIS; MYOCARDITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84942234413     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.166029     Document Type: Article

References (26)

1. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
2. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002;113:419-23.
3. Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute lupus myocarditis: Clinical features and outcome of an oriental case series. Lupus 2005;14:827-31.
4. Apte M, McGwin G Jr, Vila LM, Kaslow RA, Alarcön GS, Reveille JD, et al. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford) 2008;47:362-7.
5. Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LT Jr. A contemporary case series of lupus myocarditis. Lupus 2012;21:1378-84.
6. Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 2009;62:584-92.
7. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980;69:849-58.
8. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 2006;45 Suppl:48-53.
9. Chung JW, Joe DY, Park HJ, Kim HA, Park HS, Suh CH. Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 2008;28:275-80.
10. Appenzeller S, Pineau CA, Clarke AE. Acute lupus myocarditis: Clinical features and outcome. Lupus 2011;20:981-8.
11. George D, Erkan D. Antiphospholipid syndrome. Prog Cardiovasc Dis 2009;52:115-25.
12. Borenstein DG, Fye WB, Arnett FC, Stevens MB. The myocarditis of systemic lupus erythematosus: Association with myositis. Ann Intern Med 1978;89 (Pt 1):619-24.
13. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9.
14. Logar D, Kveder T, Rozman B, Dobovisek J. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 1990;49:627-9.
15. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
16. Aggarwal P, Singh S, Suri D, Rawat A, Narula N, ManojKumar R. Rituximab in childhood lupus myocarditis. Rheumatol Int 2012;32:1843-4.
17. Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol 2008;35:826-33.
18. Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M, et al. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: A longitudinal analysis of 52 Hispanic patients. Lupus 2010;19:213-9.
19. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779-92.
20. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.
21. Dankö K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: A longitudinal study of 162 cases. Medicine (Baltimore) 2004;83:35-42.
22. Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 2012;14:275-85.
23. Boueiz A, Mathai SC, Hummers LK, Hassoun PM. Cardiac complications of systemic sclerosis: Recent progress in diagnosis. Curr Opin Rheumatol 2010;22:696-703.
24. Tyndall AJ, Bannert B, Vonk M, Airö P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
25. Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013;65:270-81.
26. Mavrogeni S, Bratis K, Markussis V, Spargias C, Papadopoulou E, Papamentzelopoulos S, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013;22:34-43.